BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35759240)

  • 1. The relationship of 3'UTR HLA-G14-bp insertion/deletion and +3142 C/G polymorphisms and soluble HLA-G expression with gynecological cancers: An updated meta-analysis.
    Tizaoui K; Jalouli M; Boujelbene N; Harrath AH; Ouzari HI; Rizzo R; Zidi I
    Immun Inflamm Dis; 2022 Jul; 10(7):e645. PubMed ID: 35759240
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Gan J; Di XH; Yan ZY; Gao YF; Xu HH
    Front Immunol; 2022; 13():1076040. PubMed ID: 36618382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3'UTR-HLA-G polymorphisms and circulating sHLA-G are associated with breast cancer: Evidence from a meta-analysis.
    Tizaoui K; Jalouli M; Ouzari HI; Harrath AH; Rizzo R; Boujelbene N; Zidi I
    Immunol Lett; 2022 Aug; 248():78-89. PubMed ID: 35752280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of HLA-G 14bp insertion/deletion polymorphism and soluble HLA-G revealed an association with digestive cancers initiation and prognosis.
    Dhouioui S; Boujelbene N; Ouzari HI; Tizaoui K; Zidi I
    Heliyon; 2022 Jul; 8(7):e09986. PubMed ID: 35874075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of HLA-G Polymorphisms in the 3'UTR Region and Soluble HLA-G with Kidney Graft Outcome.
    Durmanova V; Bandzuchova H; Zilinska Z; Tirpakova J; Kuba D; Buc M; Polakova K
    Immunol Invest; 2019 Aug; 48(6):644-658. PubMed ID: 31094243
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of
    Gautam S; Kumar U; Kumar M; Kanga U; Dada R
    Immunol Invest; 2020 Feb; 49(1-2):88-105. PubMed ID: 31549885
    [No Abstract]   [Full Text] [Related]  

  • 7. High Amounts of Total and Extracellular Vesicle-Derived Soluble HLA-G are Associated with HLA-G 14-bp Deletion Variant in Women with Embryo Implantation Failure.
    Nardi Fda S; Slowik R; Michelon T; Manvailer LF; Wagner B; Neumann J; Horn P; Bicalho Mda G; Rebmann V
    Am J Reprod Immunol; 2016 Jun; 75(6):661-71. PubMed ID: 26959830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of HLA-G 3' untranslated region polymorphisms in human papillomavirus infection.
    Bortolotti D; Gentili V; Rotola A; Di Luca D; Rizzo R
    Tissue Antigens; 2014 Feb; 83(2):113-8. PubMed ID: 24397524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation sites at the HLA-G 3' untranslated region confer differential susceptibility to HIV/HPV co-infection and aneuploidy in cervical cell.
    Medeiros FS; Martins AES; Gomes RG; de Oliveira SAV; Welkovic S; Maruza M; Menezes MLB; Ximenes RAA; Diniz GTN; Donadi EA; Lucena-Silva N
    PLoS One; 2018; 13(10):e0204679. PubMed ID: 30278059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
    Li T; Huang H; Liao D; Ling H; Su B; Cai M
    Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease.
    Misra MK; Prakash S; Kapoor R; Pandey SK; Sharma RK; Agrawal S
    Tissue Antigens; 2013 Nov; 82(5):317-26. PubMed ID: 24131018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New markers for predictions of acute and chronic rejection and graft outcomes in kidney transplant recipients; HLA-G gene 3'UTR 14 bp polymorphism and sHLA-G.
    Darbas S; Yilmaz VT; Kocak H; Kisaoglu A; Demiryilmaz I; Aydinli B; Arslan HS; Ucar F
    Gene; 2021 Jul; 790():145712. PubMed ID: 33984446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation between soluble human leukocyte antigen (sHLA-G) levels and +3010 polymorphism.
    Alyami A; AlJurayyan A; Alosaimi B; Alkadi H; Alkhulaifi F; Al-Jurayb H; Osman A; Christmas S; Alomar S; Al-Bayati Z
    Int J Immunogenet; 2024 Feb; 51(1):39-46. PubMed ID: 38087909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-G 14 bp insertion/deletion polymorphism and its association with sHLA-G levels in Behçet's disease Tunisian patients.
    Sakly K; Maatouk M; Hammami S; Harzallah O; Sakly W; Feki S; Mirshahi M; Ghedira I; Sakly N
    Hum Immunol; 2016 Jan; 77(1):90-95. PubMed ID: 26519864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-G 3' untranslated region polymorphisms influence the susceptibility for human papillomavirus infection.
    Xu HH; Shi WW; Lin A; Yan WH
    Tissue Antigens; 2014 Aug; 84(2):216-22. PubMed ID: 24758208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of HLA-G 3'UTR polymorphisms and haplotypes with colorectal cancer susceptibility and prognosis.
    Dhouioui S; Laaribi AB; Boujelbene N; Jelassi R; Ben Salah H; Bellali H; Ouzari HI; Mezlini A; Zemni I; Chelbi H; Zidi I
    Hum Immunol; 2022 Jan; 83(1):39-46. PubMed ID: 34763955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population.
    Martelli-Palomino G; Pancotto JA; Muniz YC; Mendes-Junior CT; Castelli EC; Massaro JD; Krawice-Radanne I; Poras I; Rebmann V; Carosella ED; Rouas-Freiss N; Moreau P; Donadi EA
    PLoS One; 2013; 8(10):e71742. PubMed ID: 24204558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble HLA-G levels in seminal plasma are associated with HLA-G 3'UTR genotypes and haplotypes.
    Craenmehr MHC; Haasnoot GW; Drabbels JJM; Spruyt-Gerritse MJ; Cao M; van der Keur C; Kapsenberg JM; Uyar-Mercankaya M; van Beelen E; Meuleman T; van der Hoorn MP; Heidt S; Claas FHJ; Eikmans M
    HLA; 2019 Oct; 94(4):339-346. PubMed ID: 31321883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in the
    Jiang Y; Lu J; Wu YE; Zhao X; Li L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30962267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-G 14bp Ins/Del Polymorphism in the 3'UTR Region and Acute Rejection in Kidney Transplant Recipients: An Updated Meta-Analysis.
    Kang SW; Oh E; Cho W; Kim M; Park EJ; Kwack KH; Chung K; Nam OH; Chae YK; Ban JY
    Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.